Skip to main content
Advertisement
Browse Subject Areas
?

Click through the PLOS taxonomy to find articles in your field.

For more information about PLOS Subject Areas, click here.

  • Loading metrics

Sex differences in associations between multimorbidity and physical function domains among community-dwelling adults in Singapore

  • Lixia Ge ,

    Roles Conceptualization, Data curation, Formal analysis, Investigation, Methodology, Project administration, Resources, Validation, Visualization, Writing – original draft, Writing – review & editing

    lixia_ge@nhg.com.sg

    Affiliation Health Services and Outcomes Research, National Healthcare Group Pte Ltd, Singapore, Singapore

  • Chun Wei Yap,

    Roles Data curation, Project administration, Supervision, Validation, Writing – review & editing

    Affiliation Health Services and Outcomes Research, National Healthcare Group Pte Ltd, Singapore, Singapore

  • Bee Hoon Heng

    Roles Funding acquisition, Project administration, Supervision, Writing – review & editing

    Affiliation Health Services and Outcomes Research, National Healthcare Group Pte Ltd, Singapore, Singapore

Abstract

Objectives

The aims of the study were to identify the associations between multimorbidity and specific physical function domains among community-dwelling adults in Singapore, and to examine sex differences in the associations.

Methods

This study was conducted using baseline data of 1,940 participants in the Population Health Index Survey conducted in the Central Region of Singapore from November 2015 to November 2016. Physical function was assessed using the Function Component of the Late-life Function and Disability Instrument and compared between men and women. Multiple linear regressions were conducted to examine associations between multimorbidity and different physical function domains for all participants, and in men and women separately.

Results

The prevalence of multimorbidity in the study population was 35.0% for adults aged 21 years and above, with no differences between men and women. Multimorbidity was associated with reduced upper extremity function, basic and advanced lower extremity function, and overall function in men and women after adjusting for demographic factors. Multimorbidity had a stronger association with advanced lower extremity function and overall physical function in women than in men.

Conclusions

The findings of this study indicate that multimorbidity is associated with physical function domains in men and women, and in particular advanced lower extremity for women. Effective community-based interventions need to be implemented to preserve physical function in individuals with multimorbidity to keep them functionally independent and physically active in the community. Additional focus on advanced lower extremity function for women is needed.

Introduction

People living with multiple chronic diseases have become a common phenomenon because of therapeutic advances and increased longevity. Multimorbidity, the co-presence of two or more chronic medical conditions in an individual [1], requires complex care management and has become a large burden to the healthcare system and society [26]. Estimates of multimorbidity prevalence vary widely, ranging from 24.5% [7] to 98.5% [8]. It depends on countries, settings (primary care or community), sources of data (survey, administrative database, chart reviews or clinical evaluations), number and types of chronic diseases considered and individual characteristics like sex and age [8,9]. Although it is consistently reported in scientific literature that multimorbidity prevalence increases with age, more than half of the population with multimorbidity are younger than 65 years [10,11]. Hence, the increasing prevalence of multimorbidity in young and middle-aged adults should not be overlooked.

Limitations in physical function are great concerns to public health as they are highly associated with various negative health outcomes like decreased quality of life, increased risk of disability and level of dependency, increased health care utilization and costs [12]. Studies have shown that chronic diseases like stroke, heart diseases, chronic pulmonary diseases, osteoarthritis, depression and cognitive impairment can cause decline in physical function [13]. Furthermore, prior literature has documented the association between number of chronic diseases and poorer physical function in older adults [14,15]. While limited, a few large and rigorous studies in recent years (e.g. the Nurses’ Health Study II) have also reported lower physical function in young and middle-aged adults with multimorbidity [16,17]. Importantly, the cumulative impact of multimorbidity increases the likelihood of functional decline beyond the risk attributable to individual diseases [18,19]. However, the majority of these studies were conducted among older population and focused mainly on general physical function measured using physical health component of quality of life instruments, with few studies exploring the associations between multimorbidity and specific domains of physical function (i.e. upper and lower extremity function) among general community-dwelling adult population. Additionally, little is known about whether there is any sex difference with respect to the associations between multimorbidity and different domains of physical function, despite sex differences in physical performance and physical dysfunction were documented in literature [20,21]. Hence, the current study was conducted to examine the associations between multimorbidity and specific domains of physical function among community-dwelling men and women and to determine whether there are sex differences in the associations.

Methods

Data source and study population

This study was conducted as a cross-sectional analysis of baseline data derived from the Population Health Index (PHI) survey. This was a longitudinal household survey on the health of a representative sample of community-dwelling adult population (aged 21 and above) living in the Central Region of Singapore. Details of the study methodology have been previously described [22]. Briefly, eligible individuals (Singapore citizens or permanent residents, aged 21 years and above, having stayed in randomly selected household units for more than 6 months in the past year) were randomly selected using Kish grid tables [23] during house visits and underwent detailed structured interviews conducted by trained surveyors. Individuals were excluded from the survey if they were incapable of responding to the questionnaire due to mental health conditions, severe intellectual disability or cognitive impairment, or any communication issues (including language barriers, hearing loss, verbal aphasia following stroke) unless a proxy (usually a family member or caregiver who was most familiar with the individual’s condition) was available to give consent and provide the required information.

A total of 1,942 eligible individuals (including 17 proxy interviews) participated in the baseline PHI survey between November 2015 and November 2016. The response rate of the baseline PHI survey was 53.3%. Only participants with complete responses to the primary outcome measure of physical function (n = 1,940) were selected for the analyses.

The PHI survey was approved by the ethical committee of the National Healthcare Group Domain Specific Review Board (DSRB, Reference Number: 2015/00269). Written informed consent was obtained from individual participants in the survey.

Measures

Physical function.

The 32-item Function Component of the Late-life Function and Disability Instrument (LLFDI) [24] was used to measure physical function of the participants (S1 Appendix). The LLFDI was developed from the conceptual scheme of disablement to evaluate function and disability for community-dwelling older adults. The Function Component of the LLFDI evaluates self-reported difficulties in performing 32 routine physical activities of daily life which consist of three domains: upper extremity functioning (UEF, 7 items that reflect activities of the hands and arms), basic lower extremity functioning (BLEF, 14 items that reflect activities primarily involving standing, squatting, and fundamental walking activities), and advanced lower extremity functioning (ALEF, 11 items reflecting activities that involve a high level of physical ability and endurance) (S2 Appendix). Questions are phrased “How much difficulty do you have [doing a particular activity] without the help of someone else and without the use of any assistive walking device?”. Each question has five response options: “5 = None”, “4 = A little”, “3 = Some”, “2 = Quite a lot”, and “1 = Cannot do”. As a comprehensive measure that focuses on discrete actions or activities rather than narrow basic physical skills, the Function Component of the LLFDI is effective in capturing variations in function in the general population [24]. Multiple studies have evaluated the psychometric properties of the Function Component of the LLFDI and shown that it is a reliable and valid measure for physical function [2527]. The LLFDI overall function and its three separate domains in the present study demonstrated high level of reliability (Cronbach's alpha of 0.973 for overall function and 0.897–0.961 for individual domains).

Scoring of the Function Component includes an overall function score and three separate earlier mentioned domain scores. The raw summary score of all 32 items and each domain was transformed based on a one-parameter Rasch model to a scaled score (0–100) in order to have the overall function score and all the domain scores on a similar metric [28]. Scores approaching 100 represent high levels in ability to perform discrete actions and activities without assistance while scores approaching 0 represent low levels in ability.

The proxies of the 17 participants who were incapable to report by themselves were asked to rate how they (the proxy) thought the participants would rate their own responses if able to communicate it.

Chronic diseases and multimorbidity.

In this study chronic diseases referred to diseases that are irreversible and persistent through adulthood [17]. Seventeen chronic diseases (with similar diseases treated as one group) were used to determine multimorbidity. These were dyslipidemia, high blood pressure, diabetes, chronic kidney disease (CKD), heart attack / ischemic heart disease (IHD), heart failure, stroke / transient ischemic attack (TIA), asthma, chronic bronchitis / emphysema / chronic obstructive pulmonary disease (COPD), cancer, osteoarthritis / gout / rheumatoid arthritis (RA), osteoporosis, depression, anxiety disorder, schizophrenia, dementia / Alzheimer’s, and Parkinson’s disease. The diagnoses of these chronic diseases were obtained from two sources: 1) PHI survey data by asking the participants a specific question: “Have you ever been told to have any of these conditions [the list of the 17 chronic diseases] by a Western-trained doctor?”, and 2) the National Healthcare Group (NHG) Chronic Disease Management System (CDMS) database. This is a chronic disease registry within NHG that links administrative and key clinical data of patients with chronic diseases across the healthcare cluster in Singapore [29,30]. A total of 1,676 out of 1,940 participants (86.4%) in the PHI survey were identified in the CDMS database. A participant was considered to have a chronic disease if at least one of the two sources indicated the presence of that chronic disease, i.e. if a participant’s response to the survey question for a chronic disease was “No”, but the CDMS database showed that he/she had been diagnosed with that chronic disease, the participant was considered to have that chronic disease. Participants were stratified into three groups by number of chronic diseases: no chronic disease, 1 chronic disease, and 2 or more (2+) chronic diseases. Multimorbidity was defined as the presence of at least two of the 17 chronic diseases in this study.

Socio-demographic information.

Socio-demographic information of the participants including age (categorized into 3 groups: 21–44, 45–64, and ≥65 years), sex, ethnicity (Chinese, Malay, Indian, and others), highest education level (no formal education, primary, secondary, and post-secondary and above), and smoking status was used in this study. Self-reported frequency of physical activities were captured using two questions: “How often do you take part in active recreation (e.g. bowling, golf, tennis, hiking, jogging, swimming, etc.)” and “How often do you take part in a regular fitness program (e.g. walking for exercise, stationary biking, weight lifting, or exercise classes, etc.)” with five response options for each question: “very often”, “often”, “once in a while”, “almost never”, and “never”.

Statistical analysis

Sample weights were calculated according to a three-step procedure that included weights for the household, the household non-participant adjustment and the household member [22]. Descriptive analyses were conducted for socio-demographic characteristics with weighted mean and standard errors calculated for continuous variables, and unweighted frequencies and weighted percentages reported for categorical variables. Independent-samples t-tests or Chi-square (χ2) tests were conducted to assess differences in socio-demographic characteristics, presence of individual chronic diseases, number of chronic diseases and physical function domain scores between men and women. One-way analysis of variance (ANOVA) was used to determine the differences in physical function domains among adults with 0, 1 and 2+ chronic conditions.

Multiple linear regressions were conducted to examine the association between multimorbidity and overall function as well as individual domains of physical function. In each regression model, the dependent variable was overall function or individual physical function domain score, and the independent variable was multimorbidity, adjusted for demographics including age group, sex, ethnicity, highest education level and smoking status. Sex difference was examined by running the regressions separately for men and women, adjusted for the same covariates except sex. The regression coefficient (B) and standard error (SE) were reported. The significant level of difference between regression coefficients for the same physical function in men and women were tested using the z test [31]. Descriptive statistics were calculated using Statistical Package for Social Sciences (SPSS) version 18.0 (SPSS, Inc., Chicago, IL) and multiple linear regressions were performed using Stata/SE 12 for Windows. The result was considered significant if a p value was <0.05.

Results

Sample characteristics

The final study population comprised 1,940 participants. The weighted mean age of the study population was 51.4 years (standard deviation (SD):17.3 years, range: 21–97 years). More than half (56.1%) of the study population were women, and 78.3% were Chinese. The characteristics of the study population were summarized by sex in Table 1. The percentage of women who were current or past smokers (7.1%) was much lower than that of men (45.1%). Compared to women, participated in active recreation and regular fitness program was more frequent among men.

Prevalence of chronic diseases and multimorbidity

More than 55.0% of the study population had at least one chronic disease, and 35.0% had two or more chronic diseases. The average number of chronic diseases was 1.5 (SD: 1.9, range: 0–11) in men and 1.3 (SD: 1.7, range: 0–9) in women. There were 58.0% male and 53.4% female participants with at least one chronic disease. The prevalence of multimorbidity was 36.7% in men and 33.7% in women and these increased with increasing age in both sexes.

The most frequent chronic diseases were dyslipidemia, hypertension, and diabetes, with an overall prevalence of 35.7%, 30.4%, and 16.3%, respectively (Table 2). Dyslipidemia and hypertension were the top two common chronic diseases for both sexes. There were some differences in the pattern of chronic diseases between men and women. While men had significantly higher prevalence of hypertension, dyslipidemia, heart attack / IHD, heart failure, and chronic bronchitis / emphysema / COPD than women, their prevalence of osteoarthritis / gout / RA and depression was significantly lower (p<0.05).

thumbnail
Table 2. Sex- and age-specific prevalence of chronic diseases and multimorbidity, n (%).

https://doi.org/10.1371/journal.pone.0197443.t002

The top three combinations of chronic diseases in the study population were hypertension and dyslipidemia (4.8%), diabetes, hypertension and dyslipidemia (2.7%), hypertension, dyslipidemia and osteoarthritis / gout / RA (1.5%). Men had higher rate of co-presence of hypertension and dyslipidemia (5.6%) than women (4.2%).

Physical function domains

As shown in Table 3, both men and women reported lower scores for BLEF and ALEF than UEF. Compared to men, women reported significantly lower scores in overall function and all three domains of physical function (p<0.01). With increasing age, both men and women reported decline in overall function and all three physical function domains, and the decline in ALEF was most predominant.

thumbnail
Table 3. Physical function domain scores (mean ± SD) by sex and age group.

https://doi.org/10.1371/journal.pone.0197443.t003

Associations between multimorbidity and individual physical function domains

Fig 1 showed that with the increase in number of chronic diseases, there were significant decreases in overall function and individual domains of physical function for both men and women, of which ALEF had the most substantial decrease, followed by BLEF. Women consistently reported poorer BLEF and ALEF (p<0.05, Fig 1). However, while there was significant sex difference in UEF for those with zero or one chronic disease, the difference was not significant for those with two or more chronic diseases (p = 0.12).

thumbnail
Fig 1. Sex differences in physical function domains by number of chronic diseases.

https://doi.org/10.1371/journal.pone.0197443.g001

The linear regressions for individual physical function domains for all participants showed that having one chronic condition was negatively associated with ALEF (B = -3.54, SE = 1.11) and overall function (B = -2.87, SE = 0.82). Multimorbidity was consistently associated with lower scores of UEF (B = -4.27, SE = 0.66), BLEF (B = -8.79, SE = 0.82), ALEF (B = -14.27, SE = 1.09) and overall function (B = -10.95, SE = 0.81). Additionally, being a woman was associated with lower scores in all physical function domains (Table 4).

thumbnail
Table 4. Associations between multimorbidity and physical function domains using multiple linear regressions.

https://doi.org/10.1371/journal.pone.0197443.t004

Table 5 below shows the multiple linear regression results of the associations between multimorbidity and individual physical function domains stratified by sex. Having one chronic disease was inversely associated with ALEF (B = -4.68, SE = 1.49) and overall function (B = -3.61, SE = 1.09) in women only. Multimorbidity was significantly associated with the decline in upper and lower extremity function in both men and women. The comparison between respective regression coefficients showed that multimorbidity had stronger association with ALEF (z-score = 1.91, p<0.01) and overall function (z-score = 1.60, p = 0.02) in women than in men.

thumbnail
Table 5. Sex differences in associations between multimorbidity and physical function domains using multiple linear regressions.

https://doi.org/10.1371/journal.pone.0197443.t005

Discussion

This study showed that multimorbidity was associated with reduced upper extremity function, basic and advanced lower extremity function, and overall function measured using self-reported LLFDI in community-dwelling adults. The associations of multimorbidity with advanced lower extremity function and overall physical function were stronger in women than in men.

The estimated prevalence of multimorbidity in this study was 35.0% for adults aged 21 years and above and 68.2% for those aged 60 years and above. This is higher than 16.3% [32] and 51.5% [6] for the respective population reported in other local studies, and is similar to 30% reported among Spanish general population aged 20 years and above [33]. Because men had higher prevalence of the top three common chronic diseases (including hypertension, dyslipidemia and diabetes), the proportion of men having multimorbidity in the present study was slightly higher than that of women, though this is not statistically significant. This is contrary to the findings of some European studies which found that multimorbidity was more prevalent in older women than in older men [34,35]. This may be due to the differences in types and/or prevalence of the chronic diseases included and the age structure for men and women.

The negative association between multimorbidity and individual domains of physical function among community-dwelling adults in this study is in concordance with that found in one previous study in older individuals [36]. This can be explained by physical activity reduction, muscle mass and strength decrease, or physiological impairment caused by chronic diseases [3639]. As reported by Melissa et al.[17], younger adults with multimorbidity also reported lower physical function, the significant associations after controlling for age group and other covariates in the study also indicates that multimorbidity’s negative impact on physical function is independent of aging and other demographics. Compared to UEF (e.g., unscrewing the lid of an unopened jar, pouring water from a large pitcher, holding a full glass of water, etc.), LEF especially ALEF (e.g. going up and down three flights of stairs, hiking a couple of kilometers on uneven surfaces, running 800 meters or more, etc.) declines more substantially with increase in number of chronic diseases in both men and women. A possible reason is that skeletal muscle dysfunction, a combination of reduced muscle strength and endurance, is one of the major secondary impairments associated with pathological changes caused by chronic diseases which predominantly affects the lower extremity muscles, while the muscle function is better preserved in the upper extremity [4042]. Other possible reasons could include the type / prevalence of chronic diseases included (e.g. Parkinson’s disease affects UEF but is less prevalent) and potential measurement issues (UEF is assessed using fewer items than LEF and those upper extremity activities require relatively less energy and endurance).

Consistent with previous studies in middle-aged and older adults in Denmark and Russia [43], and Germany [44] using SF-36 physical functioning subscale, the results in this study also showed that women reported poorer physical function than men. The sex difference was most obvious in ALEF with a mean score difference of 4.5. This is probably due to the differences in body composition between men and women [20]. Men are generally superior in muscle strength, muscle endurance, whole-body endurance, and walking ability compared to women [45]. Despite the difference in chronic diseases prevalence, consistent associations between multimorbidity and individual domains of physical function were observed in both men and women. Compared to men, multimorbidity had stronger association with ALEF in women, which suggests that women’s ALEF is more vulnerable to multimorbidity than men’s.

Furthermore, as whole-body and muscle endurance, muscle strength and walking ability decrease with age [4546], the decline of various physical functions with age in both men and women were also observed in the present study. Similar to the findings reported in an European study [47], lower education level was also associated with poorer physical function for both sexes. Furthermore, Malay males reported poorer physical function than Chinese males, which is consistent with the current ethnic differences in physical health in Singapore [48].

As a population-based health survey, the PHI survey questionnaire was administered to a representative study population, the findings of the study are generalizable to the general adult population in the Central Region of Singapore. However, there are a few limitations in this study. Firstly, self-reporting of chronic diseases may lead to an underestimation of the prevalence of chronic diseases. This risk was partially mitigated through the use of a chronic disease registry. However, as the CDMS database contains only patients who were seen in NHG institutions, participants whose chronic diseases were treated at other institutions or private general practitioners are still subjected to measurement error introduced by self-report. Secondly, using a simple disease count may not be sufficient to represent the full association between multimorbidity and physical function [17]. This is because a simple disease count does not take into account the severity of individual chronic diseases contributing to physical function decline and fails to identify any specific interactions of different chronic diseases that are driving physical function impairment. The use of complex approaches to measure multimorbidity (e.g. severity-weighted multimorbidity index and cluster analysis) may provide deeper insights on the association between multimorbidity and physical function. Finally, the cross-sectional nature of the present study prevents identification of causal relationships between chronic diseases and decline in physical function.

Conclusions

The findings of this study show that multimorbidity is associated with individual domains of physical function in men and women, particularly among older women. Considering the high prevalence of multimorbidity among community-dwelling adults and its substantial association with different domains of physical function, healthcare system needs to take effective community-based interventions to preserve physical function in individuals with multimorbidity in order to keep them functionally independent and physically active in the community. Additional focus on advanced lower extremity function for women is needed.

Supporting information

S1 Appendix. 32-item Function Component of the Late-life Function and Disability Instrument (LLFDI).

https://doi.org/10.1371/journal.pone.0197443.s001

(PDF)

S2 Appendix. Items used to assess specific physical function domains in the Function Component of the LLFDI.

https://doi.org/10.1371/journal.pone.0197443.s002

(PDF)

Acknowledgments

The authors are thankful to Ruijie Li and Wei Ling Ng for valuable and constructive inputs during the planning and development of the PHI survey, Reuben Ong for administrative assistance with project management, all the trained surveyors for assistance with data collection and all the subjects whose participation made this study possible.

References

  1. 1. Smith SM, O’Dowd T. Chronic diseases: what happens when they come in multiples? Br J Gen Pract J R Coll Gen Pract. 2007;57: 268–270.
  2. 2. Fortin M, Soubhi H, Hudon C, Bayliss EA, Akker M van den. Multimorbidity’s many challenges. BMJ. 2007;334: 1016–1017. pmid:17510108
  3. 3. Wang L, Palmer AJ, Cocker F, Sanderson K. Multimorbidity and health-related quality of life (HRQoL) in a nationally representative population sample: implications of count versus cluster method for defining multimorbidity on HRQoL. Health Qual Life Outcomes. 2017;15: 7. pmid:28069026
  4. 4. Marengoni A, Angleman S, Melis R, Mangialasche F, Karp A, Garmen A, et al. Aging with multimorbidity: a systematic review of the literature. Ageing Res Rev. 2011;10: 430–439. pmid:21402176
  5. 5. Fortin M, Bravo G, Hudon C, Lapointe L, Almirall J, Dubois M-F, et al. Relationship between multimorbidity and health-related quality of life of patients in primary care. Qual Life Res. 2006;15: 83–91. pmid:16411033
  6. 6. Picco L, Achilla E, Abdin E, Chong SA, Vaingankar JA, McCrone P, et al. Economic burden of multimorbidity among older adults: impact on healthcare and societal costs. BMC Health Serv Res. 2016;16: 173. pmid:27160080
  7. 7. García-Olmos L, Salvador CH, Alberquilla Á, Lora D, Carmona M, García-Sagredo P, et al. Comorbidity patterns in patients with chronic diseases in general practice. PLOS ONE. 2012;7. pmid:22359665
  8. 8. Fortin M, Bravo G, Hudon C, Vanasse A, Lapointe L. Prevalence of multimorbidity among adults seen in family practice. Ann Fam Med. 2005;3: 223–228. pmid:15928225
  9. 9. Fortin M, Hudon C, Haggerty J, van den Akker M, Almirall J. Prevalence estimates of multimorbidity: a comparative study of two sources. BMC Health Serv Res. 2010;10: 111. pmid:20459621
  10. 10. Taylor AW, Price K, Gill TK, Adams R, Pilkington R, Carrangis N, et al. Multimorbidity—not just an older person’s issue. Results from an Australian biomedical study. BMC Public Health. 2010;10: 718. pmid:21092218
  11. 11. Barnett K, Mercer SW, Norbury M, Watt G, Wyke S, Guthrie B. Epidemiology of multimorbidity and implications for health care, research, and medical education: a cross-sectional study. The Lancet. 2012;380: 37–43.
  12. 12. Painter P, Stewart AL, Carey S. Physical functioning: definitions, measurement, and expectations. Adv Ren Replace Ther. 1999;6: 110–123. pmid:10230878
  13. 13. Griffith L, Raina P, Wu H, Zhu B, Stathokostas L. Population attributable risk for functional disability associated with chronic conditions in Canadian older adults. Age Ageing. 2010;39: 738–745. pmid:20810673
  14. 14. Jindai K. Multimorbidity and functional limitations among adults 65 or older, NHANES 2005–2012. Prev Chronic Dis. 2016;13. pmid:27809419
  15. 15. Stenholm S, Westerlund H, Head J, Hyde M, Kawachi I, Pentti J, et al. Comorbidity and functional trajectories from midlife to old age: the Health and Retirement Study. J Gerontol Ser A. 2015;70: 332–338. pmid:25060316
  16. 16. Aarts S, den Akker M van, Bosma H, Tan F, Verhey F, Metsemakers J, et al. The effect of multimorbidity on health related functioning: temporary or persistent? Results from a longitudinal cohort study. J Psychosom Res. 2012;73: 211–217. pmid:22850262
  17. 17. Wei MY, Kawachi I, Okereke OI, Mukamal KJ. Diverse cumulative impact of chronic diseases on physical health–related quality of life: implications for a measure of multimorbidity. Am J Epidemiol. 2016;184: 357–365. pmid:27530335
  18. 18. Fried LP, Bandeen-Roche K, Kasper JD, Guralnik JM. Association of comorbidity with disability in older women: the Women’s Health and Aging Study. J Clin Epidemiol. 1999;52: 27–37. pmid:9973071
  19. 19. Tinetti ME, Fried T. The end of the disease era. Am J Med. 2004;116: 179–185. pmid:14749162
  20. 20. Tseng LA, Delmonico MJ, Visser M, Boudreau RM, Goodpaster BH, Schwartz AV, et al. Body composition explains sex differential in physical performance among older adults. J Gerontol A Biol Sci Med Sci. 2014;69: 93–100. pmid:23682159
  21. 21. Formiga F, Pujol R, Pérez-Castejon JM, Ferrer A, Henríquez E, De Llobregat SF. Low comorbidity and male sex in nonagenarian community-dwelling people are associated with better functional and cognitive abilities: the nonasantfeliu study. J Am Geriatr Soc. 2005;53: 1836–1837. pmid:16181194
  22. 22. Ge L, Yap CW, Ong R, Heng BH. Social isolation, loneliness and their relationships with depressive symptoms: a population-based study. PLOS ONE. 2017;12: e0182145. pmid:28832594
  23. 23. Kish L. A procedure for objective respondent selection within the household. J Am Stat Assoc. 1949;44: 380–387.
  24. 24. Haley SM, Jette AM, Coster WJ, Kooyoomjian JT, Levenson S, Heeren T, et al. Late Life Function and Disability Instrument II. Development and evaluation of the Function component. J Gerontol Ser A. 2002;57: M217–M222.
  25. 25. Beauchamp MK, Schmidt CT, Pedersen MM, Bean JF, Jette AM. Psychometric properties of the Late-Life Function and Disability Instrument: a systematic review. BMC Geriatr. 2014;14: 12. pmid:24476510
  26. 26. Kupzyk KA, Seo Y, Yates B, Pozehl B, Norman J, Lowes B. Use of the Late-Life Function and Disability Instrument for measuring physical functioning in patients with heart failure. J Nurs Meas. 2016;24: 323–336. pmid:27535318
  27. 27. LaPier TK. Utility of the Late Life Function and Disability Instrument as an outcome measure in patients participating in outpatient cardiac rehabilitation: a preliminary study. Physiother Can. 2012;64: 53–62. pmid:23277685
  28. 28. Jette AM, Haley SM, Kooyoomjian JT. Late-Life FDI Manual [Internet]. MA: Boston University; 2006. Available: https://www.bu.edu/sph/files/2011/06/LLFDI_Manual_2006_rev.pdf
  29. 29. Toh MPHS, Leong HSS, Lim BK. Development of a diabetes registry to improve quality of care in the National Healthcare Group in Singapore. Ann Acad Med Singapore. 2009;38: 546–546. pmid:19565107
  30. 30. Heng BH, Sun Y, Cheah JTS, Jong M. The Singapore National Healthcare Group Diabetes Registry—descriptive epidemiology of type 2 diabetes mellitus. Ann Acad Med Singapore. 2010;39: 348–352. pmid:20535422
  31. 31. Paternoster R, Brame R, Mazerolle P, Piquero A. Using the correct statistical test for the equality of regression coefficients. Criminology. 1998;36: 859–866.
  32. 32. Subramaniam M, Abdin E, Picco L, Vaingankar JA, Chong SA. Multiple chronic medical conditions: prevalence and risk factors—results from the Singapore Mental Health Study. Gen Hosp Psychiatry. 2014;36: 375–381. pmid:24713327
  33. 33. Loza E, Jover JA, Rodriguez L, Carmona L. Multimorbidity: prevalence, effect on quality of life and daily functioning, and variation of this effect when one condition is a rheumatic disease. Semin Arthritis Rheum. 2009;38: 312–319. pmid:18336872
  34. 34. Garin N, Olaya B, Moneta MV, Miret M, Lobo A, Ayuso-Mateos JL, et al. Impact of multimorbidity on disability and quality of life in the Spanish older population. PLOS ONE. 2014;9: e111498. pmid:25375890
  35. 35. Walker V, Perret-Guillaume C, Kesse-Guyot E, Agrinier N, Hercberg S, Galan P, et al. Effect of multimorbidity on health-related quality of life in adults aged 55 years or older: Results from the SU.VI.MAX 2 Cohort. PLOS ONE. 2016;11: e0169282. pmid:28033414
  36. 36. Welmer A-K, Kåreholt I, Angleman S, Rydwik E, Fratiglioni L. Can chronic multimorbidity explain the age-related differences in strength, speed and balance in older adults? Aging Clin Exp Res. 2012;24: 480–489. pmid:22961066
  37. 37. Padilla J, Krasnoff J, Da Silva M, Hsu C-Y, Frassetto L, Johansen KL, et al. Physical functioning in patients with chronic kidney disease. J Nephrol. 2008;21: 550–559. pmid:18651545
  38. 38. Kalyani RR, Corriere M, Ferrucci L. Age-related and disease-related muscle loss: the effect of diabetes, obesity, and other diseases. Lancet Diabetes Endocrinol. 2014;2: 819–829. pmid:24731660
  39. 39. Kuo H-K, Jones RN, Milberg WP, Tennstedt S, Talbot L, Morris JN, et al. Effect of blood pressure and diabetes mellitus on cognitive and physical functions in older adults: a longitudinal analysis of the advanced cognitive training for independent and vital elderly cohort. J Am Geriatr Soc. 2005;53: 1154–1161. pmid:16108933
  40. 40. Debigaré R, Maltais F. The major limitation to exercise performance in COPD is lower limb muscle dysfunction. J Appl Physiol Bethesda Md 1985. 2008;105: 751–753; discussion 755–757. pmid:18678623
  41. 41. Franssen FME, Wouters EFM, Baarends EM, Akkermans MA, Schols AMWJ. Arm mechanical efficiency and arm exercise capacity are relatively preserved in chronic obstructive pulmonary disease. Med Sci Sports Exerc. 2002;34: 1570–1576. pmid:12370557
  42. 42. IJzerman TH, Schaper NC, Melai T, Meijer K, Willems PJB, Savelberg HHCM. Lower extremity muscle strength is reduced in people with type 2 diabetes, with and without polyneuropathy, and is associated with impaired mobility and reduced quality of life. Diabetes Res Clin Pract. 2012;95: 345–351. pmid:22104262
  43. 43. Oksuzyan A, Shkolnikova M, Vaupel JW, Christensen K, Shkolnikov VM. Sex differences in health and mortality in Moscow and Denmark. Eur J Epidemiol. 2014;29: 243–252. pmid:24668060
  44. 44. Buttery AK, Du Y, Busch MA, Fuchs J, Gaertner B, Knopf H, et al. Changes in physical functioning among men and women aged 50–79 years in Germany: an analysis of National Health Interview and Examination Surveys, 1997–1999 and 2008–2011. BMC Geriatr. 2016;16. pmid:27908276
  45. 45. Sugimoto H, Demura S, Nagasawa Y. Age and gender-related differences in physical functions of the elderly following one-year regular exercise therapy. Health (N Y). 2014;06: 792–801.
  46. 46. Beenakker KGM, Ling CH, Meskers CGM, de Craen AJM, Stijnen T, Westendorp RGJ, et al. Patterns of muscle strength loss with age in the general population and patients with a chronic inflammatory state. Ageing Res Rev. 2010;9: 431–436. pmid:20553969
  47. 47. Hu Y, Pikhart H, Pająk A, Kubínová R, Malyutina S, Besala A, et al. Education, material condition and physical functioning trajectories in middle-aged and older adults in Central and Eastern Europe: a cross-country comparison. J Epidemiol Community Health. 2016;70: 1128–1135. pmid:27194710
  48. 48. Liu JJ, Lim SC, Yeoh LY, Su C, Tai BC, Low S, et al. Ethnic disparities in risk of cardiovascular disease, end-stage renal disease and all-cause mortality: a prospective study among Asian people with Type 2 diabetes. Diabet Med. 2016;33: 332–339. pmid:26514089